4.7 Editorial Material

The early interferon catches the SARS-CoV-2

Related references

Note: Only part of the references are listed.
Editorial Material Critical Care Medicine

Nebulised interferon beta-1a for patients with COVID-19 Comment

Nathan Peiffer-Smadja et al.

LANCET RESPIRATORY MEDICINE (2021)

Review Biochemistry & Molecular Biology

Type I and III interferon responses in SARS-CoV-2 infection

You-Me Kim et al.

Summary: Researchers have reviewed how SARS-CoV-2 manipulates the immune system by inhibiting host IFN responses, leading to delayed and exaggerated inflammation, which contributes to the severity of COVID-19. Further investigations are needed to better understand the mechanisms behind these immune system dysfunctions caused by the virus.

EXPERIMENTAL AND MOLECULAR MEDICINE (2021)

Article Immunology

Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs

Jonathan Lopez et al.

Summary: The nasal IFN-I/III signature in mildly symptomatic COVID-19 patients correlates with serum IFN-a(2) levels, while critically ill patients with autoantibodies against IFN-I showed low nasal IFN-I/III scores despite high viral loads. Functional assays confirmed the role of autoantibodies in compromising the antiviral effects of IFN-I at the early stages of SARS-CoV-2 infection.

JOURNAL OF EXPERIMENTAL MEDICINE (2021)

Article Immunology

Dynamic innate immune response determines susceptibility to SARS-CoV-2 infection and early replication kinetics

Nagarjuna R. Cheemarla et al.

Summary: Initial replication of SARS-CoV-2 in the upper respiratory tract is crucial for establishing infection, and the host innate immune defenses play a significant role in restricting early infection. The activity of interferon-stimulated genes (ISGs) impacts viral replication and transmission during infection, and cross-reactive antiviral responses induced by different viruses can provide protection against SARS-CoV-2.

JOURNAL OF EXPERIMENTAL MEDICINE (2021)

Article Biochemistry & Molecular Biology

Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19

Daniel Blanco-Melo et al.

Article Multidisciplinary Sciences

Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

Qian Zhang et al.

SCIENCE (2020)

Article Multidisciplinary Sciences

Autoantibodies against type I IFNs in patients with life-threatening COVID-19

Paul Bastard et al.

SCIENCE (2020)

Editorial Material Medicine, General & Internal

Virology, transmission, and pathogenesis of SARS-CoV-2

Muge Cevik et al.

BMJ-BRITISH MEDICAL JOURNAL (2020)

Review Immunology

Shared and Distinct Functions of Type I and Type III Interferons

Helen M. Lazear et al.

IMMUNITY (2019)

Review Immunology

Interferon-omega: Current status in clinical applications

Shi-fang Li et al.

INTERNATIONAL IMMUNOPHARMACOLOGY (2017)

Article Immunology

IKKε and TBK1 are essential components of the IRF3 signaling pathway

KA Fitzgerald et al.

NATURE IMMUNOLOGY (2003)